One of the most comprehensive looks at the use of hormone therapy in women over 65 with non-metastatic breast cancer found some welcome news. Except for frail patients, most participants in the large study complied with their oncologists’ recommendations to treat their estrogen-positive breast cancer with hormone therapy – either an aromatase inhibitor or tamoxifen.

READ FULL ARTICLE Curated publisher From Science Codex